Abstract

Purpose To quantify extracellular matrix expansion with the cardiovascular magnetic resonance (CMR) T1 mapping technique and the derived extracellular volume fraction (ECV) in diabetic cardiomyopathy (DbCM) patients and to detect the relationship among ECV, duration of diabetes, and diastolic function. Materials Thirty-eight patients with diabetic cardiomyopathy (20 males, age 54.6 ± 8.6 years) and thirty-two matched normal controls (15 males, age 51.4 ± 13.6 years) were prospectively enrolled. All of them were scanned by T1 mapping to obtain the native and postcontrast T1 values of myocardium and blood, and ECV was calculated accordingly. All patients also underwent transthoracic echocardiographic tissue Doppler imaging to assess left-ventricular diastolic function. Results There was a significant difference in ECV between the two groups (DbCMs 30.4 ± 2.9% versus controls 27.1 ± 2.4%, P < 0.001). The duration of diabetes was positively and strongly associated with ECV (R = 0.539, P = 0.0005). There was also a significant difference in ECV (P ≤ 0.001) among four groups (A, controls; B, DbCM patients with duration of diabetes <5 years; C, 5–10 years; and D, >10 years). ECV was negatively associated with LV E'/A' (R = −0.403, P = 0.012). Conclusion CMR T1 mapping can reflect myocardial extracellular matrix expansion in DbCM and can be a powerful technique for the early diagnosis of DbCM.

Highlights

  • Type 2 diabetes mellitus (T2DM), one of the most common chronic diseases globally, affects nearly four hundred million individuals [1]

  • Diabetic cardiomyopathy (DbCM) was associated with higher TG, highdensity lipoprotein cholesterol (HDL), aspartate aminotransferase (AST), ischemia modified albumin (IMA), and troponin levels

  • Using cardiac MR, we found that (1) DbCM is accompanied by increased extracellular volume fraction (ECV), which indicates extracellular volume expansion; (2) ECV is associated with the duration of diabetes; and (3) increased ECV correlates with reduced tissue Doppler imaging (TDI) E’/A’

Read more

Summary

Introduction

Type 2 diabetes mellitus (T2DM), one of the most common chronic diseases globally, affects nearly four hundred million individuals [1]. Diabetic cardiomyopathy (DbCM), which is present in almost two-thirds of patients with T2DM, is defined as myocardial dysfunction occurring independently of coronary artery disease, valvular dysfunction, or hypertension [2, 3]. Pathologic biopsy is a gold standard for assessing myocardial fibrosis. Whereas many techniques have been developed to assess myocardial fibrosis (such as CT, echocardiography, SPECT, and PET), these are less accurate than contrast-enhanced cardiovascular magnetic resonance (CMR) [5]. The conventional CMR late gadolinium enhancement (LGE) method, the validation, and prognostic advantages of which have been examined extensively in a variety of pathologic studies have been

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call